In the first
clinical study comparing SonoCiné and mammography,
20 cancers were found. SonoCiné detected 18 of these
breast cancers and mammography detected 15. Since this
first study, SonoCiné has discovered 7 additional
cancers missed by physical exam and/or mammography. Also,
traditional ultrasound produces only 30 permanent images
of the breast compared to 2,000 to 5,000
permanent images
produced by SonoCiné.
Further substantiation of the process is currently being tested in an FDA-sanctioned,
multi-center clinical trial.
"SonoCiné detected two malignant tumors, one in each
breast of my patient B.G., that were missed by the mammogram she'd
had only two months earlier. She immediately underwent surgery
and today is cancer free. SonoCiné probably
saved her life. SonoCiné
is
breakthrough investigational technology for early breast cancer detection."
--David M. Faddis, MD, Oncological Surgeon, Immediate
Past President of the Medical Staff at Huntington Memorial Hospital,
Pasadena, CA
|
This site contains information about breast ultrasound imaging
for healthcare providers and equipment vendors.
SonoCiné is an investigational ultrasound process that
transfers sonographic cine loops or video streams to a Windows™-based
computer. It optimizes viewing conditions including review speed,
image size, contrast and brightness in both two and three dimensional
formats. Entire breast ultrasound image studies are permanently
stored on CD. For more information on SonoCiné, visit our
FAQs. At present, SonoCiné
is being used for whole-breast ultrasound cancer detection. Although
still investigational, it has found cancers that were missed by
mammography and conventional ultrasound exams. In the future,
SonoCiné
will have applications for echocardiography (where videotapes could
be replaced), orthopedic and vascular ultrasound and other uses.
Although SonoCiné currently only interfaces with the latest
Siemens
Acuson Sequoia™ and the Philips HDI 5000™, its technology is adaptable to
other platforms.
|
